A primary care perspective on the use of continuous glucose monitoring in clinical practice

Diabetes Technology and Therapeutics

Volumn 15, Issue 7, 2013, Pages 533-537

  Bhide, Manisha ^a   Grey, Jessica M S ^b   Moser, Emily G ^b,c   Garg, Satish K ^b,c  

^a UNIVERSITY OF COLORADO HOSPITAL   (United States)

^b UNIVERSITY OF COLORADO DENVER   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; SHORT ACTING INSULIN;

BLOOD GLUCOSE MONITORING; CLINICAL PRACTICE; DIABETES MELLITUS; DIABETIC DIET; DIABETIC PATIENT; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEALTH CARE COST; HEALTH CARE QUALITY; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REIMBURSEMENT; REVIEW;

ATTITUDE OF HEALTH PERSONNEL; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; EXTRACELLULAR FLUID; GLUCOSE; HUMANS; MONITORING, AMBULATORY; PHYSICIANS; PRIMARY HEALTH CARE;

EID: 84880259593     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2013.0169     Document Type: Review

References (20)

1. World Health Organization: Obesity: Preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 2000;894: I-xii, 1-253
2. Mokdad AH, Bowman BA, Ford ES, Vinicor F: The continuing epidemics of obesity and diabetes in the United States. JAMA 2001;286:1195-1200
3. CDC Behavioral Risk Factor Surveillance System: Prevalence of obesity among U.S. adults. 2011. www.cdc.gov/obesity/ data/adult.html (accessed May 23, 2013
4. Østbye T, Yarnall KSH, Krause KM, Pollack KI, Gradison M, Michener JL: Is there time for management of patients with chronic diseases in primary care? Ann Fam Med 2005;3:209-214
5. Beck RW, Tamborlane WV, Bergenstal RM, Miller KM, DuBose SN, Hall CA: The T1D Exchange Clinic Registry. J Clin Endocrinol Metab 2012;97:4383-4389
6. Diabetes Control and Complications Trial (DCCT): Results of feasibility study. The DCCT Research Group. Diabetes Care 1987;10:1-19
7. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, Tamborlane WV, Beck RW, Bode BW, Buckingham B, Chase HP, Clemons R, Fiallo-Scharer R, Fox LA, Gilliam LK, Hirsch IB, Huang ES, Kollman C, Kowalski AJ, Laffel L, Lawrence JM, Lee J, Mauras N, ÓGrady M, Ruedy KJ, Tansey M, Tsalikian E, Weinzimer S, Wilson DM, Wolpert H, Wysocki T, Xing D: Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med 2008;359:1464-1476
8. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group: Effectiveness of continuous glucose monitoring in a clinical care environment: Evidence from the Juvenile Diabetes Research Foundation continuous glucose monitoring (JDRF-CGM) trial. Diabetes Care 2010; 33:17-22
9. Garg SK, Reed K, Grey J, Westerman A: Possibly impacts of new accuracy standards of self-monitoring of blood glucose. US Endocrinol 2013;9:26-29
10. Moser EG, Garg SK: Glucose monitoring. Treat Strategies Diabetes 2011;3:81-85
11. Garg SK, Voelmle MK, Beatson CR, Miller HA, Crew LB, Freson BJ, Hazenfield RM: Use of continuous glucose monitoring in subjects with type 1 diabetes on multiple daily injections versus continuous subcutaneous insulin infusion therapy. Diabetes Care 2011;34:574-579
12. Edelman SV, Bailey TS: Continuous glucose monitoring health outcomes. Diabetes Technol Ther 2009;11:68-74
13. Fabiato K, Buse J, Duclos M, Largay J, Izlar C, ÓConnell T, Stallings J, Dungan K: Clinical experience with continuous glucose monitoring in adults. Diabetes Technol Ther 2009; 11:93-103
14. Blevins TC, Bode BW, Garg SK, Grunberger G, Hirsch IB, Jovanovic L, Nardacci E, Orzeck EA, Roberts VL, Tamborlane WV; AACE Continuous Glucose Monitoring Task Force: Statement by the American Association of Clinical Endocrinologists Consensus Panel on continuous glucose monitoring. Endocr Pract 2010;16:730-745
15. Garg S: Rationale for the use of insulin pumps and continuous glucose monitoring in adult patients. Endocr Pract 2012:18(Suppl 2):10-12
16. McGlynn EA, Asch SM, Adams J, Keesey J, Hicks J, Decristofaro A, Kerr EA: The quality of health care delivered to adults in the United States. N Engl J Med 2003;348:2635-2645
17. Gilliam LK, Hirsch IB: Practical aspects of real-Time continuous glucose monitoring. Diabetes Technol Ther 2009;11: 75-82
18. Bergenstal RM, Ahmann AJ, Bailey T, Beck RW, Buckingham B, Deeb L, Dolin R, Garg SK, Goland R, Hirsch I, Klonoff DC, Kruger DF, Matfin G, Mazze R, Parkin C, Peters A, Rodriguez, Southerland P, Strock ES, Tamborlane W, Wesley DM: Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in type 1 diabetes: The ambulatory glucose profile (AGP). Diabetes Technol Ther 2013;15:198-211
19. Vigersky RA, Fonda SJ, Chellappa M, Walker MS, Ehrhardt NM: Short-And long-Term effects of real-Time continuous glucose monitoring in patients with type 2 diabetes. Diabetes Care 2012;35:32-38
20. Garg S, Hirsch IB: Self-monitoring of blood glucose -An overview. ATTD 2012 Yearbook, Diabetes Technol Ther 2013;15(Suppl 1):1-23